Anbio Biotechnology(NNNN.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Anbio Biotechnology
NNNN.US
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care testing, and laboratory markets. Anbio Biotechnology was incorporated in 2021 and is based in Frankfurt am Main, Germany.
1.813 T
NNNN.USMarket value -Rank by Market Cap -/-

Financial Score

19/05/2026 Update
B
BiotechnologyIndustry
Industry Ranking25/386
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE27.05%A
    • Profit Margin74.06%A
    • Gross Margin87.24%A
  • Growth ScoreB
    • Revenue YoY5.64%C
    • Net Profit YoY169.86%A
    • Total Assets YoY59.83%A
    • Net Assets YoY75.41%A
  • Cash ScoreD
    • Cash Flow Margin-105.24%E
    • OCF YoY5.64%C
  • Operating ScoreD
    • Turnover0.35D
  • Debt ScoreA
    • Gearing Ratio0.29%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Anbio Biotechnology Posts Solid FY25 Results, Diversifies Portfolio

    benzinga_article·
    US
    SBIO
    -0.98%
    US
    XHE
    +1.02%
    US
    BBH
    +0.73%
    benzinga_article·
    US
    SBIO
    -0.98%
    US
    XHE
    +1.02%
    US
    BBH
    +0.73%

    International Biotechnology (LON:IBT) Stock Price Crosses Above 200-Day Moving Average - Time to Sell?

    Market Beat·
    US
    BBH
    +0.73%
    US
    XBI
    -0.38%
    US
    UNBX
    0.00%
    Market Beat·
    US
    BBH
    +0.73%
    US
    XBI
    -0.38%
    US
    UNBX
    0.00%

    Drug developer Generate Biomedicines raises $400 million in US IPO

    fidelity·
    US
    XBI
    -0.38%
    US
    IHI
    +1.16%
    US
    XHE
    +1.02%
    fidelity·
    US
    XBI
    -0.38%
    US
    IHI
    +1.16%
    US
    XHE
    +1.02%

    Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering | GENB Stock News

    StockTitan·
    US
    PBE
    +0.30%
    US
    FBT
    +0.63%
    US
    XBI
    -0.38%
    StockTitan·
    US
    PBE
    +0.30%
    US
    FBT
    +0.63%
    US
    XBI
    -0.38%

    Biotech Firm Generate Biomedicines Plans $425 Million IPO Amid Sector Growth

    CoinLive·
    US
    BBH
    +0.73%
    US
    NNNN
    +6.94%
    US
    PBE
    +0.30%
    CoinLive·
    US
    BBH
    +0.73%
    US
    NNNN
    +6.94%
    US
    PBE
    +0.30%
    © 2026 Longbridge｜Disclaimer